Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy

Journal of Hypertension

Volumn 17, Issue 5, 1999, Pages 597-601

  Rave, Klaus ^a   Bender, Ralf ^a   Heise, Tim ^a   Sawicki, Peter T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Blood pressure determination methods; Blood pressure self measurement; Diabetic nephropathy; Office blood pressure

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOME MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS;

EID: 0033055985     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917050-00002     Document Type: Article

References (35)

1. 1 Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28:590-596.
2. 2 Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M. Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 1995; 13:933-938.
3. 3 Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1:1175-1179.
4. 4 Maki DD, Ma JZ, Louis TA, Kasiske BL. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155:1073-1080.
5. 5 Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effects of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engf J Med 1993; 329:1456-1462.
6. 6 Sawicki PT. Stabilisation of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimes. Nephrol Dial Transplant 1997; 12:1890-1899.
7. 7 Parving H-H. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981; 20:457-461.
8. 8 Rossing P, Hommel E, Smidt UM, Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in insulin-dependent diabetes. Diabetes 1993; 42:715-719.
9. 9 Pickering TG. Blood pressure measurement and detection of hypertension. Lancet 1994; 344:31-35.
10. 10 de Gaudemaris R, Chau NP, Mallion JM. Home blood pressure: variability, comparison with office readings and proposal for reference values. Groupe de la Mesure, French Society of Hypertension. J Hypertens 1994; 12:831-838.
11. 11 Burgess E, Mather K, Ross S, Josefsberg Z. Office hypertension in type 2 (non-insulin-dependent) diabetic patients [Letter]. Diabetologia 1991; 34:684.
12. 12 Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11:1403-1411.
13. 13 Mühlhauser I, Sawicki P, Didjurgeit U, Jörgens V, Berger M. Uncontrolled hypertension in type 1 diabetes: assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme. Diabetic Med 1988; 5:693-698.
14. 14 Sawicki P, Mühlhauser I, Didjurgeit U, Berger M. Effects of intensification of antihypertensive care in diabetic nephropathy. J Diab Complications 1995; 9:315-317.
15. 15 Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu Tirgoviste C, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 1987; 30:681-690.
16. 16 Sawicki PT, Heinemann L, Berger M. Comparison of methods for determination of microalbuminuria in diabetic patients. Diabetic Med 1989; 6:412-415.
17. 17 Sampson MJ, Drury PL. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine. Diabetes Care 1992; 15:609-612.
18. 18 Maroni B, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27:58-65.
19. 19 Ibrahim MM, Tarazi RC, Dustan HP, Gifford RW Jr. Electrocardiogram in evaluation of resistance to antihypertensive therapy. Arch Intern Med 1977; 137:1125-1129.
20. 20 Sakuma M, Imai Y, Tsuji I, Nagai K, Ohkubo T, Watanabe N, et al. Predictive value of home blood pressure measurement in relation to stroke morbidity: a population-based pilot study in Ohasama, Japan. Hypertens Res 1997; 20:167-174.
21. 21 Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364.
22. 22 Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens 1997; 10:798-803.
23. 23 James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH. The reproducibility of average ambulatory, home, and clinic pressures. Hypertension 1988; 11:545-549.
24. 24 Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993; 118:867-882.
25. 25 The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1997; 157:2413-2445.
26. 26 Self-measurement of blood pressure: a statement by the World Hypertension League. J Hypertens 1988; 6:257-261.
27. 27 The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-183.
28. 28 Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 1997; 40:405-411.
29. 29 Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, et al. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 1993; 36:1087-1093.
30. 30 Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant 1996; 11:461-467.
31. 31 Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. O J Med 1988; 67:343-354.
32. 32 Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 1988; 34:382-388.
33. 33 Parving H-H, Rossing P, Hommel E, Smidt UM. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis 1995; 26:99-107.
34. 34 Nyberg G, Blohme G, Norden G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetohgia 1987; 30:82-86.
35. 35 Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified Insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329:304-309.